Profiel
Dr. Yariv J.
Houvras is a Chief Medical Officer at Xilio Therapeutics, Inc. Dr. Houvras was previously employed as a SVP-Clinical & Translational Development by Tubulis GmbH.
He received his undergraduate degree from the University of Michigan and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Actieve functies van Yariv Houvras
| Bedrijven | Functie | Begin |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 28-09-2026 |
Eerdere bekende functies van Yariv Houvras
| Bedrijven | Functie | Einde |
|---|---|---|
Tubulis GmbH
Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors | Corporate Officer/Principal | - |
Opleiding van Yariv Houvras
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Tubulis GmbH
Tubulis GmbH BiotechnologyHealth Technology Develops and manufactures antibody-drug conjugates with biophysical properties to treat cancer tumors | Health Technology |
















